Vivo Capital, LLC Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$1.2T
Holdings
47
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (47 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SLNOSoleno Therapeutics Inc | 2,278,203 | $154.0B | 12.39% | |
| 2 | VRNAVerona Pharma PLC | 1,393,432 | $148.7B | 11.97% | |
| 3 | CDTXCidara Therapeutics, Inc. | 1,311,425 | $125.6B | 10.11% | |
| 4 | TERNTerns Pharmaceuticals Inc | 6,895,746 | $51.8B | 4.17% | |
| 5 | TRVITrevi Therapeutics Inc | 5,094,668 | $46.6B | 3.75% | |
| 6 | AVDLAvadel Pharmaceuticals PLC | 2,684,109 | $41.0B | 3.30% | |
| 7 | COGTCogent Biosciences Inc | 2,789,137 | $40.1B | 3.22% | |
| 8 | SVASinovac Biotech Ltd. | 5,903,000 | $38.2B | 3.07% | |
| 9 | ORICOric Pharmaceuticals Inc | 3,126,604 | $37.5B | 3.02% | |
| 10 | GONGeron Corp | 27,225,292 | $37.3B | 3.00% | |
| 11 | CMPXCompass Therapeutics Inc | 9,545,466 | $33.4B | 2.69% | |
| 12 | DYNDyne Therapeutics Inc | 2,614,960 | $33.1B | 2.66% | |
| 13 | ABVXAbivax SA - ADR | 359,305 | $30.5B | 2.45% | |
| 14 | DRUGBright Minds Biosciences Inc | 501,617 | $30.4B | 2.45% | |
| 15 | TRMLTourmaline Bio Inc. | 591,882 | $28.3B | 2.28% | |
| 16 | ZBIOZenas Biopharma Inc | 1,183,260 | $26.3B | 2.11% | |
| 17 | VSTMVerastem Inc | 2,644,985 | $23.4B | 1.88% | |
| 18 | SABSSAB Biotherapeutics Inc | 11,420,000 | $23.0B | 1.85% | |
| 19 | VRDNViridian Therapeutics Inc | 982,576 | $21.2B | 1.71% | |
| 20 | AKROAkero Therapeutics Inc | 434,689 | $20.6B | 1.66% | |
| 21 | ERASErasca Inc | 9,273,428 | $20.2B | 1.63% | |
| 22 | RZLTRezolute Inc | 2,112,432 | $19.9B | 1.60% | |
| 23 | ACRSAclaris Therapeutics, Inc. | 8,888,888 | $16.9B | 1.36% | |
| 24 | CRVSCorvus Pharmaceuticals Holdings | 2,234,566 | $16.5B | 1.33% | |
| 25 | OLMAOlema Pharmaceuticals Inc | 1,505,862 | $14.7B | 1.19% | |
| 26 | DNTHDianthus Therapeutics Inc | 353,998 | $13.9B | 1.12% | |
| 27 | LBRXLB Pharmaceuticals Inc | 800,000 | $12.6B | 1.02% | |
| 28 | CAMPCAMP4 Therapeutics Inc | 3,921,568 | $11.8B | 0.95% | |
| 29 | CATBUSDAstria Therapeutics Inc | 1,552,685 | $11.3B | 0.91% | |
| 30 | PEPGPepgen Inc | 2,325,000 | $10.7B | 0.86% | |
| 31 | DBVTDBV Technologies SA | 1,054,506 | $10.5B | 0.85% | |
| 32 | PRAXPraxis Precision Medicines | 198,895 | $10.5B | 0.85% | |
| 33 | ABEOAbeona Therapeutics, Inc. | 1,842,751 | $9.7B | 0.78% | |
| 34 | CTMXCytomx Therapeutics Inc | 2,884,615 | $9.2B | 0.74% | |
| 35 | EPRXEupraxia Pharmaceuticals Inc | 1,350,000 | $8.0B | 0.64% | |
| 36 | UNCYUnicycive Therapeutics | 1,789,916 | $7.8B | 0.63% | |
| 37 | MNPRMonopar Therapeutics Inc | 90,500 | $7.4B | 0.59% | |
| 38 | TNGXTango Therapeutics Inc | 776,699 | $6.5B | 0.53% | |
| 39 | DCTHDelcath Systems, Inc. | 569,526 | $6.1B | 0.49% | |
| 40 | SLNSilence Therapeutics PLC | 1,105,454 | $5.7B | 0.46% | |
| 41 | ETNBGBP89Bio Inc | 376,804 | $5.5B | 0.45% | |
| 42 | TILInstil Bio Inc | 292,743 | $5.2B | 0.42% | |
| 43 | SERASera Prognostics Inc | 1,650,440 | $5.1B | 0.41% | |
| 44 | SRZNSurrozen Inc | 260,000 | $3.4B | 0.27% | |
| 45 | TENXTenax Therapeutics Inc | 208,333 | $1.6B | 0.13% | |
| 46 | BOLTBolt Therapeutics Inc | 176,064 | $936.7M | 0.08% | |
| 47 | DTILPrecision Biosciences Inc | 4,675 | $25.8M | 0.00% |